We found that COL1A2, COL3A1, COL5A2, tumor mediators targeting of relevant structural components of the extracellular matrix (ECM) were activated to drive CAFs to synthetize fibrillar collagen creating an aberrant microenvironment (22). The gene discussed is COL5A2; the disease is neoplasm.